Kansas City, KSNCT07774039Now EnrollingIRB Ready

Hematopoietic Stem Cell Transplant Clinical Trial in Kansas City, KS

Access cutting-edge hematopoietic stem cell transplant treatment through this phase 1 clinical trial at a research site in Kansas City. Study-provided care at no cost to qualified participants.

Sponsored by University of Kansas Medical Center

Quick Self-Assessment

See if you qualify for this Kansas City location

Preparing your pre-screening questions…

Expert Care in Kansas City

Access hematopoietic stem cell transplant specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related hematopoietic stem cell transplant treatment provided free

Apply for This Kansas City Location

Check if you qualify for this hematopoietic stem cell transplant clinical trial in Kansas City, KS

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Kansas City

    Convenient for KS residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Kansas City site if eligible
  4. 4Begin participation

About This Hematopoietic Stem Cell Transplant Study in Kansas City

This proposed study is a prospective, randomized, controlled Phase 1 clinical trial to determine feasibility, acceptability (Aim 1) and preliminary effect (Aim 2) to mitigate insomnia symptoms and fatigue and improve health-related quality of life in patients who are planning to undergo HSCT. The investigators plan to enroll n=30 with insomnia symptoms (Insomnia Severity Index ≥10) who will be randomized into one of two groups: 1. A group that starts CBT-I after the initial evaluation visit with the HSCT care team (Early CBT-I), or 2. Treatment as usual (TAU). Participants in the CBT-I group will receive six sessions of telehealth-delivered CBT-I that is completed prior to transplant. Reassessments will occur post-intervention (\~1-2 weeks before HSCT) and 1- and 3-months post-HSCT.

Sponsor: University of Kansas Medical Center

Who Can Participate

Inclusion Criteria

≥18 years old
≥10 on Insomnia Severity Index
Primary HSCT physician approval
English speaking

Exclusion Criteria

Known untreated sleep disorder (such as sleep apnea or restless legs syndrome)
\>3 on STOP BANG indicating increased risk of sleep apnea
Increased risk of Restless legs syndrome as determined by RLS-Diagnosis Index
Parasomnia as determined by the Sleep Disorders-Revised
If taking benzodiazepines, non-benzodiazepines, or melatonin supplements or agonists for insomnia, taking \< 3 months or dose has changed in past 3 months
T-score ≥70 on PROMIS 29+2 Anxiety or PROMIS 29+2 Depression domains indicating moderate/severe anxiety or depression
Current or history (up to 2 years) of substance use disorder involving drugs or alcohol as defined by DSM-5-TR criteria
History of other nervous system disorder such as stroke or Parkinson's disease
Severe mental illness such as schizophrenia or bipolar disorder
Severe neurological or sensory impairments that would interfere significantly with testing
History of (within 5 years) or currently conducting overnight shift work including hours of midnight-4am
Currently receiving a behavioral sleep health intervention or other behavioral health interventions that may impact sleep (such as exercise, mindfulness, CBT)

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Kansas City?

Yes, this clinical trial (NCT07774039) has an active research site in Kansas City, KS that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Hematopoietic Stem Cell Transplant Treatment Options in Kansas City, KS

If you're searching for hematopoietic stem cell transplant treatment options in Kansas City, KS, this clinical trial (NCT07774039) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Kansas City research site is actively enrolling participants for this phase 1 clinical trial. You'll receive care from experienced hematopoietic stem cell transplant specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all hematopoietic stem cell transplant clinical trials near you to find additional studies recruiting in your area.

More Essential Tremor Trials in Kansas City, KS

See all essential tremor clinical trials recruiting in Kansas City — not just this study.

Browse Essential Tremor Trials in Kansas City →

Ready to Join in Kansas City?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Kansas City, KS